Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Viktor Volok"'
Autor:
Victoria Illarionova, Anastasia Rogova, Ksenia Tuchynskaya, Viktor Volok, Yulia Rogova, Victoria Baryshnikova, Yuriy Turchenko, Alexander Litov, Anna Kalyanova, Alexandra Siniugina, Aydar Ishmukhametov, Galina Karganova
Publikováno v:
Vaccines, Vol 11, Iss 12, p 1754 (2023)
Tick-borne encephalitis virus (TBEV) and Powassan virus (POWV) are neurotropic tick-borne orthoflaviviruses. They cause mostly asymptomatic infections in hosts, but severe forms with CNS involvement can occur. Studying the early stages of viral infec
Externí odkaz:
https://doaj.org/article/1142230b1f5b41babf66fac4d88be4ea
Autor:
Veronika Kuznetsova, Alexander Tyakht, Lyudmila Akhmadishina, Vera Odintsova, Natalia Klimenko, Elena Kostryukova, Maria Vakhitova, Tatyana Grigoryeva, Sergey Malanin, Vsevolod Vladimirtsev, Raisa Nikitina, Viktor Volok, Vladimir Osakovskiy, Tatiana Sivtseva, Fyodor Platonov, Dmitry Alexeev, Galina Karganova
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-11 (2020)
Abstract Background Viliuisk encephalomyelitis (VE) is a rare endemic neurodegenerative disease occurring in the Yakut population of Northeastern Siberia. The main clinical features of VE are spasticity, dysarthria, dementia, central paresis and para
Externí odkaz:
https://doaj.org/article/6a54fddbe0f244958aa250c547830a75
Autor:
Ksenia Tuchynskaya, Viktor Volok, Victoria Illarionova, Egor Okhezin, Alexandra Polienko, Oxana Belova, Anastasia Rogova, Liubov Chernokhaeva, Galina Karganova
Publikováno v:
Microorganisms, Vol 9, Iss 6, p 1172 (2021)
Currently the only effective measure against tick-borne encephalitis (TBE) is vaccination. Despite the high efficacy of approved vaccines against TBE, rare cases of vaccine failures are well documented. Both host- and virus-related factors can accoun
Externí odkaz:
https://doaj.org/article/1d9684d356614badaf61ebd9cadb8a75
Autor:
Anastasia Piniaeva, Alexander Erovichenkov, Sergey Klotchenko, Liubov Kozlovskaya, Daria Danilenko, George Ignatyev, Viktor Volok, Nikolay Maksimov
Publikováno v:
Infectious diseases: News, Opinions, Training. 11:21-27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9a7489557935ba5086b7f472f6e4d11
https://doi.org/10.33029/2305-3496-2022-11-1-21-27
https://doi.org/10.33029/2305-3496-2022-11-1-21-27
Autor:
Andrey Kruglov, Marina Bondareva, Violetta S. Gogoleva, Iaroslav Semin, Irina Astrakhantseva, Ruslan Zvartsev, Aleksandr Lunin, Vasiliy Apolokhov, Elena Y. Shustova, Viktor Volok, Aleksey A. Ustyugov, Aydar A. Ishmukhametov, Sergei A. Nedospasov, Liubov Kozlovskaya, Marina Drutskaya
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09ece4c594fd94306f7d2fd7f3c83968
https://doi.org/10.2139/ssrn.4430397
https://doi.org/10.2139/ssrn.4430397
Autor:
Liubov Kozlovskaya, Ilya Gordeychuk, Anastasia Piniaeva, Anastasia Kovpak, Anna Shishova, Aleksandr Lunin, Elena Shustova, Vasiliy Apolokhov, Ksenia Fominykh, Yuri Ivin, Alla Kondrashova, Viktor Volok, Irina Tcelykh, Aleksandra Siniugina, Aydar Ishmukhametov
Vaccines are proven to be an effective tool in prophylaxis of severe COVID-19, but emerging mutated SARS-CoV-2 variants constantly challenge vaccines’ protectivity. We have evaluated the ability of the sera from individuals vaccinated with two vari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6469d22583fe0203425e74c290045351
https://doi.org/10.1101/2022.02.10.22270781
https://doi.org/10.1101/2022.02.10.22270781